Holdings of First Turn Management, LLC
28 declared positions · as of Mar 31, 2026
Original filing · Ten largest lines: 56 % of the equity sleeve
Sector breakdown
- Health care 15.2 %
- Unattributed 84.8 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
The quoted currency of each line, as declared.
Country breakdown
- US 91.1 %
- FR 6.6 %
- DK 2.2 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|
| 1 | US | 26 | 713.2M $ | 91.14 % |
| 2 | FR | 1 | 51.9M $ | 6.63 % |
| 3 | DK | 1 | 17.5M $ | 2.23 % |
Positions
| Rank | Company | Shares | Value | Weight |
|---|
| 1 | United Therapeutics Corp | 104,726 | 62.1M $ | |
| 2 | Abivax SA | 465,869 | 51.9M $ | |
| 3 | Bridgebio Pharma Inc | 695,718 | 51.7M $ | |
| 4 | Revolution Medicines Inc | 468,376 | 45.5M $ | |
| 5 | Apogee Therapeutics Inc | 513,770 | 43.2M $ | |
| 6 | Insmed Inc | 248,475 | 40.6M $ | |
| 7 | Nuvalent Inc | 370,344 | 37.9M $ | |
| 8 | Mirum Pharmaceuticals Inc | 400,464 | 37M $ | |
| 9 | Cogent Biosciences Inc | 947,339 | 36.5M $ | |
| 10 | Axsome Therapeutics Inc | 188,772 | 31.9M $ | |
| 11 | Ideaya Biosciences Inc | 873,838 | 29.1M $ | |
| 12 | ORIC Pharmaceuticals Inc | 2,017,284 | 25.6M $ | |
| 13 | Enliven Therapeutics Inc | 623,839 | 24.5M $ | |
| 14 | Celcuity Inc | 210,578 | 24M $ | |
| 15 | Scholar Rock Holding Corp | 446,390 | 21.9M $ | |
| 16 | Kymera Therapeutics Inc | 254,672 | 21.2M $ | |
| 17 | Cytokinetics Inc | 283,700 | 18.7M $ | |
| 18 | Dianthus Therapeutics Inc | 220,921 | 18.5M $ | |
| 19 | Palvella Therapeutics Inc | 148,093 | 18.5M $ | |
| 20 | Viridian Therapeutics Inc | 911,337 | 17.8M $ | |
| 21 | Ascendis Pharma A/S | 76,300 | 17.5M $ | |
| 22 | Fulcrum Therapeutics Inc | 2,256,109 | 17.3M $ | |
| 23 | Terns Pharmaceuticals Inc | 326,694 | 17.2M $ | |
| 24 | Vera Therapeutics Inc | 422,023 | 17M $ | |
| 25 | Natera Inc | 81,077 | 16.2M $ | |
| 26 | Erasca Inc | 867,639 | 14M $ | |
| 27 | Praxis Precision Medicines Inc | 42,441 | 13.7M $ | |
| 28 | Olema Pharmaceuticals Inc | 768,662 | 11.5M $ | |